Understanding therapeutic tolerance through a mathematical model of drug-induced resistance
Preprint
Abstract
There is growing recognition that phenotypic plasticity enables cancer cells to adapt to various environmental conditions. An example of this adaptability is the persistence of an initially sensitive population of cancer cells in the presence of therapeutic agents. Understanding the implications of this drug-induced resistance is essential for predicting transient and long-term tumor tumor dynamics subject to treatment. This paper introduces a mathematical model of this phenomenon of drug-induced resistance which provides excellent fits to time-resolved in vitro experimental data. From observational data of total numbers of cells, the model unravels the relative proportions of sensitive and resistance subpopulations, and quantifies their dynamics as a function of drug dose. The predictions are then validated using data on drug doses which were not used when fitting parameters. The model is then used, in conjunction with optimal control techniques, in order to discover dosing strategies that might lead to better outcomes as quantified by lower total cell volume.Keywords
This publication has 56 references indexed in Scilit:
- Treatment of evolving cancers will require dynamic decision supportAnnals of Oncology, 2023
- Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancerCancer Chemotherapy and Pharmacology, 2022
- Global Identifiability of Differential ModelsCommunications on Pure and Applied Mathematics, 2020
- Modeling Tumor Growth and Treatment Resistance Dynamics Characterizes Different Response to Gefitinib or Chemotherapy in Non‐Small Cell Lung CancerCPT: Pharmacometrics & Systems Pharmacology, 2020
- CasADi: a software framework for nonlinear optimization and optimal controlMathematical Programming Computation, 2018
- Application of mathematical models to metronomic chemotherapy: What can be inferred from minimal parameterized models?Cancer Letters, 2017
- Editorial overview: Antivirals and resistance: Advances and challenges aheadCurrent Opinion in Virology, 2014
- The tumor microenvironment is a dominant force in multidrug resistanceDrug Resistance Updates, 2012
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristineCancer Letters, 1993